CASP1 and Hyperglycemia: Naringin reduces hyperglycemia, inhibits the proliferation of cells induced by high glucose, and decreases the expression of inflammatory that is mediated by NLRP3 through the NLRP3-caspase-1-IL-1β/IL-18 signaling pathway [24].